271 related articles for article (PubMed ID: 24313984)
1. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?
Panatto D; Amicizia D; Tanzi E; Bianchi S; Frati ER; Zotti CM; Lai PL; Bechini A; Rossi S; Gasparini R
BMC Infect Dis; 2013 Dec; 13():575. PubMed ID: 24313984
[TBL] [Abstract][Full Text] [Related]
2. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
3. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.
Giambi C; Donati S; Carozzi F; Salmaso S; Declich S; Atti ML; Ronco G; Alibrandi MP; Brezzi S; Collina N; Franchi D; Lattanzi A; Minna MC; Nannini R; Barretta E; Burroni E; Gillio-Tos A; Macallini V; Pierotti P; Bella A
BMC Infect Dis; 2013 Feb; 13():74. PubMed ID: 23390953
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
[TBL] [Abstract][Full Text] [Related]
7. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
Carozzi F; De Marco L; Gillio-Tos A; Del Mistro A; Girlando S; Baboci L; Trevisan M; Burroni E; Grasso S; Giorgi Rossi P; Ronco G;
J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
[TBL] [Abstract][Full Text] [Related]
8. There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains.
Bell MC; Schmidt-Grimminger D; Patrick S; Ryschon T; Linz L; Chauhan SC
Gynecol Oncol; 2007 Nov; 107(2):236-41. PubMed ID: 17659767
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus genotypes among women in Hunan province, China.
Li H; Zhang J; Chen Z; Zhou B; Tan Y
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):202-5. PubMed ID: 23787251
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: A hospital-based investigation.
Cao D; Zhang S; Zhang Q; Wei X; Zhao M; Ma Q; Li Y; Wang L; Pei M; Yang T; Zhao J; Yang X
J Med Virol; 2017 Jul; 89(7):1281-1286. PubMed ID: 27935120
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
13. Detection and Genotyping of HPV DNA in a Group of Unvaccinated Young Women from Colombia: Baseline Measures Prior to Future Monitoring Program.
Puerto D; Reyes V; Lozano C; Buitrago L; Garcia D; Murillo RH; Muñoz N; Hernandez GA; Sanchez L; Wiesner C; Combita AL
Cancer Prev Res (Phila); 2018 Sep; 11(9):581-592. PubMed ID: 29991579
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and significance of high-risk human papillomavirus DNA test in southern Malaysia and Singapore.
Tay SK; Tay YK
Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):323-7. PubMed ID: 19566569
[TBL] [Abstract][Full Text] [Related]
15. Incidence, persistence, and determinants of human papillomavirus infection in a population of Inuit women in northern Quebec.
Bennett R; Cerigo H; Coutlée F; Roger M; Franco EL; Brassard P
Sex Transm Dis; 2015 May; 42(5):272-8. PubMed ID: 25868140
[TBL] [Abstract][Full Text] [Related]
16. Type-specific prevalence of human papillomavirus by cervical cytology among women in Brasov, Romania.
Moga MA; Irimie M; Oanta A; Pascu A; Burtea V
Asian Pac J Cancer Prev; 2014; 15(16):6887-92. PubMed ID: 25169541
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
18. An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain.
Moosa K; Alsayyad AS; Quint W; Gopala K; DeAntonio R
BMC Cancer; 2014 Dec; 14():905. PubMed ID: 25466757
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Thompson PJ; Ning L; Killeen J; Kamemoto L; Hernandez BY
Cancer Res; 2008 Nov; 68(21):8813-24. PubMed ID: 18974124
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S
Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
